Show simple item record

P153 Rituximab and tocilizumab and their effect on lung disease progression in scleroderma: a retrospective cohort study at a single centre

dc.contributor.authorGoldman, NR
dc.contributor.authorTynan, A
dc.contributor.authorBeesley, C
dc.contributor.authorMageed, R
dc.contributor.authorDenton, C
dc.contributor.authorOng, VH
dc.date.accessioned2023-08-17T10:22:05Z
dc.date.available2023-08-17T10:22:05Z
dc.date.issued2023-04-24
dc.identifier.issn1462-0324
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/90180
dc.publisherOxford University Press (OUP)en_US
dc.relation.ispartofRheumatology
dc.subjectLungen_US
dc.subjectSclerodermaen_US
dc.subjectRare Diseasesen_US
dc.subjectAutoimmune Diseaseen_US
dc.subjectClinical Trials and Supportive Activitiesen_US
dc.subjectClinical Researchen_US
dc.subjectInflammatory and immune systemen_US
dc.titleP153 Rituximab and tocilizumab and their effect on lung disease progression in scleroderma: a retrospective cohort study at a single centreen_US
dc.typeArticleen_US
dc.identifier.doi10.1093/rheumatology/kead104.194
pubs.issueSupplement_2en_US
pubs.notesNot knownen_US
pubs.volume62en_US


Files in this item

Thumbnail
Name:
Mageed P153 Rituximab and ...
Size:
13.55Kb
Format:
application/
Description:
Accepted version
View/Open

This item appears in the following Collection(s)

Show simple item record